1. Home
  2. L vs RVMD Comparison

L vs RVMD Comparison

Compare L & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loews Corporation

L

Loews Corporation

HOLD

Current Price

$109.48

Market Cap

22.0B

Sector

Finance

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$96.42

Market Cap

19.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
L
RVMD
Founded
1969
2014
Country
United States
United States
Employees
N/A
883
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.0B
19.2B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
L
RVMD
Price
$109.48
$96.42
Analyst Decision
Strong Buy
Analyst Count
0
17
Target Price
N/A
$120.47
AVG Volume (30 Days)
523.5K
1.6M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
0.23%
N/A
EPS Growth
24.34
N/A
EPS
7.97
N/A
Revenue
$18,454,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$411.49
P/E Ratio
$13.93
N/A
Revenue Growth
5.39
N/A
52 Week Low
$82.49
$34.00
52 Week High
$114.90
$124.49

Technical Indicators

Market Signals
Indicator
L
RVMD
Relative Strength Index (RSI) 56.54 48.24
Support Level $107.84 $93.39
Resistance Level $112.32 $101.00
Average True Range (ATR) 2.10 3.12
MACD 0.46 0.21
Stochastic Oscillator 70.49 51.05

Price Performance

Historical Comparison
L
RVMD

About L Loews Corporation

Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: